文献速递围术期管理与 ERAS

肥胖不影响腹膜透析导管功能与生存且与手术技术无关

Peritoneal dialysis catheter function and survival are not adversely affected by obesity regardless of the operative technique used.
PubMed 文献 · Surg Endosc · 2017-09-15

该回顾性研究分析2004至2014年间231例连续腹膜透析置管患者,按置管技术分为开放、基础腹腔镜和高级腹腔镜三组。结果显示各BMI类别间导管功能障碍和围术期并发症无显著差异,肥胖不增加并发症或缩短无功能障碍导管生存期。

要点

  • 肥胖不应视为腹膜透析置管的相对禁忌证
  • 各BMI类别间导管功能障碍和围术期并发症无显著差异
  • 不同置管技术下肥胖患者2年无功能障碍导管生存率无显著差异

核心结论

  • 肥胖不增加腹膜透析置管并发症或缩短无功能障碍导管生存期,与所用手术技术无关。

研究设计与样本

  • 回顾性分析2004至2014年NorthShore University HealthSystem连续231例腹膜透析置管患者。
  • 按置管技术分为开放、基础腹腔镜和高级腹腔镜三组,按BMI分为正常、超重和肥胖三组。

主要发现

  • 各BMI类别间患者人口学特征无统计学显著差异。
  • 所有患者及各技术组中,不同BMI类别间导管功能障碍和围术期并发症无统计学显著差异。
  • 所有患者中正常、超重和肥胖患者2年无功能障碍导管生存率相似(log-rank p=0.79)。
  • 各置管技术内2年无功能障碍导管生存率无显著差异:开放组log-rank p=0.87,基础腹腔镜组p=0.41,高级腹腔镜组p=0.43。
  • 肥胖队列中2年无功能障碍导管生存率:高级腹腔镜91.1%,基础腹腔镜83.5%,开放65.7%(log-rank p=0.58)。

临床怎么用

  • 肥胖终末期肾病患者可考虑腹膜透析置管,不应仅因肥胖而排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity has been considered a relative contraindication to peritoneal dialysis (PD). Surprisingly, PD catheter dysfunction rates and longevity have not been studied in the growing obese ESRD population. The aim of this study was to determine the effect of patient weight on PD catheter survival in the three insertion technique categories of advanced laparoscopy (AL), basic laparoscopy (BL), and open. METHODS: We examine retrospectively collected data on 231 consecutive PD catheter insertions at the NorthShore University HealthSystem between 2004 and 2014. Three cohorts were created based on the catheter insertion technique: open, BL using selective adhesiolysis, and AL using rectus sheath tunnel, selective omentopexy, and adhesiolysis. Primary outcomes included catheter dysfunction and catheter dysfunction-free survival for each cohort by BMI: normal weight (18.5-24.9), overweight (25-29.9), obese (≥30). Nominal variables were compared using Chi-square test, continuous variables using ANOVA or Kruskal-Wallis tests, and catheter survival was assessed using the Kaplan-Meier method with log-rank test. Statistical significance was established at 0.05. RESULTS: For the three BMI categories, there were no statistically significant differences in patient demographics. There were no statistically significant differences in catheter dysfunction or peri-operative complications by BMI category among all patients. This was also true in the AL cohort. Among all patients, similar 2-year dysfunction-free catheter survival was noted for normal weight, overweight, and obese patients (log-rank p = 0.79). This was also true across all insertion techniques: open (log-rank p = 0.87), BL (log-rank p = 0.41), AL (log-rank p = 0.43). In the obese cohort, the 2-year dysfunction-free catheter survival was 91.1% in AL, 83.5% in BL, and 65.7% in open (log-rank p = 0.58). CONCLUSION: Obesity does not increase complications or shorten dysfunction-free PD catheter survival regardless of the operative technique used. Obesity should not be considered as a relative contraindication to PD catheter placement as it confers similar technique success to normal- and overweight individuals.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Krezalek MA, Bonamici N, Kuchta K, et al. Peritoneal dialysis catheter function and survival are not adversely affected by obesity regardless of the operative technique used. Surg Endosc. 2017. PMID: 28917008. doi:10.1007/s00464-017-5852-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。